Noncommunicable diseases (NCDs) are becoming one of the main causes of morbidity and mortality in the world, which necessitates the development of effective methods for their early detection. This study aims to evaluate various methods of screening control of NCDs, including cardiovascular, oncological and metabolic diseases. The study analyzed existing approaches to screening, including questionnaires, biomarkers , instrumental studies and modern technologies such as telemedicine and artificial intelligence. A systematic review of the literature and analysis of data from medical archives determined the effectiveness of various screening methods, identified their advantages and limitations. The main results showed that a comprehensive approach to screening, including the use of both traditional and innovative methods, can significantly improve the accuracy and speed of NCD diagnosis, as well as improve treatment outcomes. The main findings of the study emphasize the importance of integrating new technologies into primary care practice to increase the availability and quality of screening activities. Practical implications of this work include the need to develop national screening programs adapted to the specifics of regions, as well as training health workers in new diagnostic methods. The social impact is to increase public awareness of the importance of early detection of NCDs and the need for regular medical monitoring. This study opens new horizons for further research in the field of screening and prevention of noncommunicable diseases and highlights the importance of a multidisciplinary approach in this area.

non-communicable diseases, screening, early diagnosis, control methods, telemedicine , artificial intelligence, biomarkers , prevention, public health, medical care.

WHO. Noncommunicable Diseases Country Profiles 2021. World Health Organization, 2021.

Murray CJL, Ikeda T., Aoki Y. Global Health Metrics: Systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 2020. Vol. 392, No. 10159. P. 684-727.

Forouzanfar MH, Alexander LT, Anderson HR Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risk factors or clusters of risk factors in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 2016. Vol. 386, No. 10010. P. 287-323.

Gaziano JM, Bitton A, Anand S. A Global Risk Assessment for Cardiovascular Disease. The New England Journal of Medicine, 2017. Vol. 376, No. 21. P. 2011-2020.

Whelton PK, Carey RM, Aronow WS 2017 Guideline for High Blood Pressure in Adults: A Report from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension , 2018. Vol. 71, No. 6. P. 113-115.

American Diabetes Association. Standards of Medical Care in Diabetes—2020. Diabetes Care, 2020. Vol. 43, Suppl 1. P. 201-212.